MADISON, N.J., Jan. 22 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors, held today, Wyeth declared dividends on both the Common and Preferred Stock of the Company.
A dividend of thirty cents ($.30) per share on the outstanding shares of Common Stock was declared payable on March 2, 2009 to stockholders of record at the close of business on February 13, 2009.
In addition, a dividend of fifty cents ($.50) per share on the outstanding shares of Preferred Stock was declared payable on April 1, 2009 to stockholders of record at the close of business on March 13, 2009.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
CONTACT: Media, Douglas Petkus, +1-973-660-5218, or investors, Justin
Victoria, +1-973-660-5340, both of Wyeth
Web site: http://www.wyeth.com/
